This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Yong Dong - Innovator in JAK Inhibitor Development
Introduction
Yong Dong is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors. His innovative work has led to advancements in the preparation of enantiomerically enriched compounds.
Latest Patents
Yong Dong holds 1 patent for a process titled "Process for preparing enantiomerically enriched JAK inhibitors." This patent discloses improved processes and intermediates for preparing ruxolitinib and its deuterated analogs. His work in this area has the potential to enhance therapeutic options for patients.
Career Highlights
Yong Dong is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions in drug formulation and synthesis.
Collaborations
Yong has collaborated with esteemed colleagues, including Robert S. Lewis and Mahender Reddy Karla. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Yong Dong's contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile